Navigation Links
Rigel to Present at the 2008 Credit Suisse Healthcare Conference
Date:11/11/2008

SOUTH SAN FRANCISCO, Calif., Nov. 11 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, Rigel's president and chief executive officer, will present a company overview at the 2008 Credit Suisse Healthcare Conference on Thursday, November 13 at 4:30 p.m. MST. The conference will be held at the Arizona Biltmore Resort in Phoenix, Arizona.

To access the live audio webcast or the subsequent archived recording, log on to http://www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (http://www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

Contact: Ryan Maynard

Phone: 650.624.1284

Email: invrel@rigel.com


'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Rigel Announces Third Quarter 2008 Financial Results and Clinical Update
2. Rigel to Host Update Conference Call
3. Rigel Announces Fourth Quarter and Year End 2007 Financial Results
4. Rigel to Present at BIO CEO & Investor Conference
5. Rigel Announces Pricing of Public Offering of Common Stock
6. Rigel to Present Research Programs at Scientific Conferences
7. Rigel to Present at BIO Investor Forum 2007
8. Interleukin Genetics to Present New Findings on Osteoporosis at the 58th Annual Meeting of the American Society of Human Genetics
9. Cynvec LLC(SM) to Present at the Rodman & Renshaw 10th Annual Healthcare Conference on November 11, 2008
10. Synvista Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
11. Genmab A/S: Ofatumumab Pivotal CLL Data to be Presented at ASH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2017)... ... June 16, 2017 , ... ... analytics solutions, today announced that its Anzo Smart Data Lake® (Anzo SDL) ... Solution’ category for the 2017 Software & Information Industry Association (SIIA) CODiE Awards. ...
(Date:6/15/2017)... New Haven, CT (PRWEB) , ... June 15, ... ... announced today that it has secured a Series B round of financing in ... Innovations, and a group of private investors participated in the round. , The ...
(Date:6/15/2017)... ... June 15, 2017 , ... DuPont Industrial Biosciences ... be speaking at Bloomberg’s 2017 Sustainable Business Summit: Seattle this Thursday, ... sustainability officials on a panel titled “Developing a Corporate Renewables Strategy.” , ...
(Date:6/14/2017)... ... June 14, 2017 , ... The Thailand ... (TCELS) announces that they’re co-hosting a delegation from Thailand at BIO 2017 in ... biotech industry gathering in the world, regroups more than 1,100 biotech companies, academic ...
Breaking Biology Technology:
(Date:4/24/2017)... April 24, 2017 Janice Kephart ... with  Identity Strategy Partners, LLP (IdSP) , today ... without President Trump,s March 6, 2017 Executive ... , refugee vetting can be instilled with greater confidence, ... now, all refugee applications are suspended by until ...
(Date:4/13/2017)... April 13, 2017 According to a new market ... Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, ... Market is expected to grow from USD 14.30 Billion in 2017 to ... of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
Breaking Biology News(10 mins):